Share Prices & Company Research

Market News

16 Oct 2020 | 16:08

Braveheart upbeat on progress with Paraytec

(Sharecast News) - Braveheart Investment Group updated the market on progress with the proof-of-concept for a Covid-19 test that Paraytec was conducting with the University of Sheffield.

The AIM-traded firm had announced on 5 October that proof-of-concept was achieved for the Optical Detection System.

Since then, the focus of the proof-of-concept trials had been on the Capture & Signal Generation Modules.

Braveheart confirmed on Friday that proof-of-concept had now been achieved for the Capture & Signal Generation Modules, meaning the proof-of-concept trials had been successfully completed.

The directors of Braveheart said they believed that the test would be the first to combine a rapid result with very high detection sensitivity.

Work would now turn toward the acquisition of clinically-relevant data, to facilitate optimisation of the functional capabilities of the test, together with a programme of product refinement and development.

Meanwhile, regulatory approval for live virus trials and the acquisition of clinical data was being sought.

"This is a phenomenal achievement for all concerned," said Braveheart chief executive officer Trevor Brown.

"The inspirational leadership and innovative brilliance of professor Carl Smythe and his talented team have resulted in proof of concept in a little over four months."

At 1347 BST, shares in Braveheart Investment Group were up 28.86% at 45.67p.
Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new account or transferring your account from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
Continuing our Personal Service: View our Latest COVID-19 Update: 16th October 2020
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.